In particular, murine LCs were shown to be dispensable over the langerin+CD103+ dermal DCs for the induction of CD8+ T cell responses in several models of viral infections, tumor or self-antigens [36–38], while some studies described LCs as essential for protective CD8+ T cell-mediated immunity [39–41]. The gene discussed is CD8A; the disease is neoplasm.